Nang Kuang Pharmaceutical Co., Ltd. Statistics
Nang Kuang Pharmaceutical Co., Ltd. (1752) Stock Statistics & Valuation Metrics
Total Valuation
Nang Kuang Pharmaceutical Co., Ltd. has a market cap or net worth of TWD 3.01B. The enterprise value is TWD 3.69B.
- Market Cap
- TWD 3.01B
- Enterprise Value
- TWD 3.69B
Share Statistics
Nang Kuang Pharmaceutical Co., Ltd. has 100,988,470 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 100,988,470
- Owned by Insiders
- ―
- Owned by Institutions
- 0.20%
Financial Efficiency
Nang Kuang Pharmaceutical Co., Ltd.’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 7.67%.
- Return on Equity (ROE)
- 0.10
- Return on Assets (ROA)
- 0.06
- Return on Invested Capital (ROIC)
- 7.67%
- Return on Capital Employed (ROCE)
- 0.11
- Revenue Per Employee
- 3.92M
- Profits Per Employee
- 441.93K
- Employee Count
- 552
- Asset Turnover
- 0.57
- Inventory Turnover
- 2.10
Valuation Ratios
The current PE Ratio of Nang Kuang Pharmaceutical Co., Ltd. is 14.70. Nang Kuang Pharmaceutical Co., Ltd.’s PEG ratio is -0.62.
- PE Ratio
- 14.70
- PS Ratio
- 1.43
- PB Ratio
- 1.24
- Price to FCF
- 21.18
- Price to Operating Cash Flow
- 8.52
- PEG Ratio
- -0.62
Income Statement
In the last 12 months, Nang Kuang Pharmaceutical Co., Ltd. had revenue of 2.16B and earned 243.95M in profits. Earnings per share was 2.42.
- Revenue
- 2.16B
- Gross Profit
- 768.86M
- Operating Income
- 295.67M
- Pretax Income
- 291.14M
- Net Income
- 243.95M
- EBITDA
- 478.81M
- Earnings Per Share (EPS)
- 2.42
Cash Flow
In the last 12 months, operating cash flow was 350.38M and capital expenditures -208.08M, giving a free cash flow of 142.30M billion.
- Operating Cash Flow
- 350.38M
- Free Cash Flow
- 142.30M
- Free Cash Flow per Share
- 1.42
Dividends & Yields
Nang Kuang Pharmaceutical Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of 5.37%
- Dividend Per Share
- ―
- Dividend Yield
- 5.37%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 4.72%
- Earnings Yield
- 6.83%
Stock Price Statistics
- Beta
- 0.29
- 52-Week Price Change
- -23.29%
- 50-Day Moving Average
- 31.32
- 200-Day Moving Average
- 32.44
- Relative Strength Index (RSI)
- 31.67
- Average Volume (3m)
- 68.11K
Important Dates
Nang Kuang Pharmaceutical Co., Ltd. upcoming earnings date is Feb 25, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 06, 2026
- Next Earnings Date
- Feb 25, 2027
- Ex-Dividend Date
- ―
Financial Position
Nang Kuang Pharmaceutical Co., Ltd. as a current ratio of 1.40, with Debt / Equity ratio of 26.41%
- Current Ratio
- 1.40
- Quick Ratio
- 0.78
- Debt to Market Cap
- 0.17
- Net Debt to EBITDA
- 0.65
- Interest Coverage Ratio
- 34.41
Taxes
In the past 12 months, Nang Kuang Pharmaceutical Co., Ltd. has paid 47.20M in taxes.
- Income Tax
- 47.20M
- Effective Tax Rate
- 0.16
Enterprise Valuation
Nang Kuang Pharmaceutical Co., Ltd. EV to EBITDA ratio is 7.41, with an EV/FCF ratio of 23.44.
- EV to Sales
- 1.58
- EV to EBITDA
- 7.41
- EV to Free Cash Flow
- 23.44
- EV to Operating Cash Flow
- 9.52
Balance Sheet
Nang Kuang Pharmaceutical Co., Ltd. has TWD 383.56M in cash and marketable securities with TWD 684.64M in debt, giving a net cash position of -TWD 301.09M billion.
- Cash & Marketable Securities
- TWD 383.56M
- Total Debt
- TWD 684.64M
- Net Cash
- -TWD 301.09M
- Net Cash Per Share
- -TWD 2.98
- Tangible Book Value Per Share
- TWD 24.04
Margins
Gross margin is 34.81%, with operating margin of 12.39%, and net profit margin of 9.66%.
- Gross Margin
- 34.81%
- Operating Margin
- 12.39%
- Pretax Margin
- 11.52%
- Net Profit Margin
- 9.66%
- EBITDA Margin
- 21.33%
- EBIT Margin
- 12.76%
Analyst Forecast
The average price target for Nang Kuang Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -7.50%
- EPS Growth Forecast
- -23.52%
